2,6-DIFLUORO DOLUTEGRAVIR (25 mg) ((4R,12aS)-N-(2,6-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide )

2,6-DIFLUORO DOLUTEGRAVIR (25 mg) ((4R,12aS)-N-(2,6-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide )

In Stock

Ready to ship

Catalogue No.

1A12930

CAS No.

2244161-72-4

Molecular Formula

C₂₀H₁₉F₂N₃O₅

Product Type

Pharmaceutical Analytical Impurities

$875.00

Shipping information

Click Here to learn more about Pharmaceutical Analytical Impurities (PAI). PAI products are different from official USP Reference Standards. This material is an Analytical Material and not a USP Reference Standard.

Additional information

Additional information

Current Lot Information

Current Lot:

F268F0

CAS RN®

2244161-72-4

Harmonized System (HS) Code *:

29349990

UN No:

N/A

NDC No:

N/A

Molecular Formula

C₂₀H₁₉F₂N₃O₅

Container Type:

VIAL

Base Control Substance (substance %):

N | A

Product Information

SDS:

USP Certificates/Product Information Sheets and Valid Use Dates

Lot No	USP Certificates/Product Information Sheets and Valid Use Dates	Valid Use Date	Country of Origin*	Material Origin*
F268F0	1A12930-F268F0	See Product Information Sheet	India	Chemical Synthesis


Lot No F268F0	USP Certificates/Product Information Sheets and Valid Use Dates Chemical Synthesis
Valid Use Date See Product Information Sheet
Country of Origin* India
Material Origin* No data available

Lot No

F268F0

USP Certificates/Product Information Sheets and Valid Use Dates

Chemical Synthesis

Valid Use Date

See Product Information Sheet

Country of Origin*

India

Material Origin*

No data available

Frequently bought together

2,6-DIFLUORO DOLUTEGRAVIR (25 mg) ((4R,12aS)-N-(2,6-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide )

Catalogue No.

1A12930

CAS No.

2244161-72-4

Molecular Formula

C₂₀H₁₉F₂N₃O₅

Product Type

Pharmaceutical Analytical Impurities

$875.00

INDOMETHACIN HYDRAZINE ANALOG (25 mg) (1-(4-Chlorobenzoyl)-1-(4-methoxyphenyl)-2-(4-chlorobenzoyl)hydrazide)

Catalogue No.

1A10010

CAS No.

402849-27-8

Molecular Formula

C₂₁H₁₆Cl₂N₂O₃

Product Type

Pharmaceutical Analytical Impurities

$450.00

OXINDOLE (25 mg) (1,3-Dihydro-2H-indol-2-one)

Catalogue No.

1A09990

CAS No.

59-48-3

Molecular Formula

C₈H₇NO

Product Type

Pharmaceutical Analytical Impurities

$475.00

OMEPRAZOLE DIHYDROPYRIDINE (25 mg) (1-(5-Methoxy-1H-benzimidazol-2-yl)-3,5-dimethyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid )

11-CHLORO BECLOMETHASONE DIPROPIONATE (25 mg) (9,11?-Dichloro-16?-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropionate)

N-ETHYL ESMOLOL (25 mg) (Methyl 3-{4-[3-(ethylamino)-2-hydroxypropoxy]phenyl}propionate)

NONACOSANE (100 mg) (Nonacosane)

PIRFENIDONE DIMER (25 mg) (1,1'-(1,4-Phenylene)bis(5-methylpyridin-2(1H)-one))

LEVOTHYROXINE BENZAMIDE (25 mg) (4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzamide)

4-NITROIMIDAZOLEETHANOL (25 mg) (2-(4-nitro-1H-imidazol-1-yl)ethanol )

R-GLYCIDYL LINEZOLID (25 mg) ((R)-3-Fluoro-4-morpholino-N-(oxiran-2-ylmethyl)aniline )

RISPERIDONE CIS-N-OXIDE MONOHYDRATE (25 mg) (cis-3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one, N-oxide monohydrate)

2,6-DIFLUORO DOLUTEGRAVIR (25 mg) ((4R,12aS)-N-(2,6-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide )